Cargando…
Current Evidence and Future Perspectives on HuR and Breast Cancer Development, Prognosis, and Treatment
Hu-antigen R (HuR) is an RNA-binding posttranscriptional regulator that belongs to the Hu/ELAV family. HuR expression levels are modulated by a variety of proteins, microRNAs, chemical compounds, or the microenvironment, and in turn, HuR affects mRNA stability and translation of various genes implic...
Autores principales: | Kotta-Loizou, Ioly, Vasilopoulos, Spyridon N., Coutts, Robert H.A., Theocharis, Stamatios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071540/ https://www.ncbi.nlm.nih.gov/pubmed/27764700 http://dx.doi.org/10.1016/j.neo.2016.09.002 |
Ejemplares similares
-
Clinical Significance and Biological Role of HuR in Head and Neck Carcinomas
por: Levidou, Georgia, et al.
Publicado: (2018) -
HuR Protein in Hepatocellular Carcinoma: Implications in Development, Prognosis and Treatment
por: Papatheofani, Vasiliki, et al.
Publicado: (2021) -
Reduced nuclear export of HuR mRNA by HuR is linked to the loss of HuR in replicative senescence
por: Yi, Jie, et al.
Publicado: (2010) -
Mycoviruses: Past, Present, and Future
por: Kotta-Loizou, Ioly
Publicado: (2019) -
Divulging the Critical Role of HuR in Pancreatic Cancer as a Therapeutic Target and a Means to Overcome Chemoresistance
por: Goutas, Dimitrios, et al.
Publicado: (2021)